Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | TPMT | P51580 | 5/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA3 | P07451 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 2/20 | 0.42 |
| ▸ | CA6 | P23280 | 2/20 | 0.42 |
| ▸ | CA5A | P35218 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.42 |
| ▸ | SELL | P14151 | 2/20 | 0.42 |
| ▸ | SELP | P16109 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18677528 | 0.84 | TDP1 (0.55) | TDP1HSD17B10MAPTPTGS2TPMT | |
| SCHEMBL9716404 | 0.81 | TDP1 (0.47) | TDP1HSD17B10MAPTPTGS2TPMT | |
| SCHEMBL28151802 | 0.79 | HSD17B10 (0.45) | HSD17B10MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL25378470 | 0.77 | TPMT (0.47) | TDP1HSD17B10MAPTPTGS2TPMT | |
| SCHEMBL15524402 | 0.77 | MAPT (0.47) | TDP1HSD17B10MAPTPTGS2TPMT | |
| SCHEMBL619429 | 0.77 | TPMT (0.47) | TDP1HSD17B10MAPTPTGS2TPMT | |
| SCHEMBL1438720 | 0.76 | TDP1 (0.59) | TDP1HSD17B10MAPTPTGS2TPMT | |
| SCHEMBL31058988 | 0.76 | TDP1 (0.61) | TDP1HSD17B10MAPTPTGS2TPMT | |
| SCHEMBL13064873 | 0.76 | TPMT (0.46) | TDP1HSD17B10MAPTPTGS2TPMT | |
| SCHEMBL670626 | 0.74 | TPMT (0.49) | TDP1HSD17B10MAPTPTGS2TPMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2611453-B1 | ANTIFUNGAL COMPOSITION | COMVITA NEW ZEALAND LTD (NZ) | 2021-08-18 | — | — | EP | disclosed |
| US-20130273020-A1 | ANTIFUNGAL COMPOSITION | COMVITA NEW ZEALAND LIMITED (NZ) | 2013-10-17 | — | — | US | disclosed |
| US-20120021061-A1 | MEDICAL AND NUTRITIONAL FORMULATIONS | COMVITA NEW ZEALAND LIMITED (NZ) | 2012-01-26 | — | — | US | disclosed |
| US-20110287059-A1 | HONEY ANALYSIS | COMVITA NEW ZEALAND LIMITED (NZ) | 2011-11-24 | — | — | US | disclosed |
| EP-2367444-A1 | MEDICAL AND NUTRITIONAL FORMULATIONS | Comvita New Zealand Limited (NZ) | 2011-09-28 | — | — | EP | disclosed |
| EP-2368111-A1 | HONEY ANALYSIS | Comvita New Zealand Limited (NZ) | 2011-09-28 | — | — | EP | disclosed |
| WO-2010082844-A1 | PLANT MANIPULATION | COMVITA NEW ZEALAND LIMITED (NZ) | 2010-07-22 | — | — | WO | disclosed |
| WO-2010082845-A1 | HONEY ANALYSIS | COMVITA NEW ZEALAND LIMITED (NZ) | 2010-07-22 | — | — | WO | disclosed |
| WO-2010082846-A1 | MEDICAL AND NUTRITIONAL FORMULATIONS | COMVITA NEW ZEALAND LIMITED (NZ) | 2010-07-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120021061-A1 | MEDICAL AND NUTRITIONAL FORMULATIONS | FABP6, NNT, IAPP | TDP1 4823/4885HSD17B10 875/4885MAPT 2491/4885 |
| US-20110287059-A1 | HONEY ANALYSIS | GLO1, GLMN, AGER | TDP1 4229/4885HSD17B10 1263/4885MAPT 3311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.